Text this: A Candidate Ac₃-S-LPS Vaccine Against <i>S. flexneri</i> 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized 2 Clinical Trial